Clinical significance of combined detection of anti-Mullerian hormone and follicular output rate in women of late reproductive age

被引:2
|
作者
Su, Hui [1 ]
Zuo, Lili [4 ]
Wu, Yangyang [2 ]
Niu, Lisong [5 ]
Wu, Yan [3 ]
Sun, Hairu [1 ]
机构
[1] Hengshui Peoples Hosp, Dept Reprod Med, 180 Renmin East Rd, Hengshui 053000, Hebei, Peoples R China
[2] Hengshui Peoples Hosp, Dept Gynaecol, Hengshui 053000, Hebei, Peoples R China
[3] Hengshui Peoples Hosp, Dept Lab, Hengshui 053000, Hebei, Peoples R China
[4] Hengshui Second Peoples Hosp, Hlth Management Ctr, Hengshui 053000, Hebei, Peoples R China
[5] Fourth Peoples Hosp Hengshui, Dept Lab, Hengshui 053000, Hebei, Peoples R China
来源
关键词
AMH; FORT; women of late reproductive age; ovarian reserve function; INTRACYTOPLASMIC SPERM INJECTION; FERTILITY DECLINE; PREGNANCY; AMH;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: This study was designed to explore the clinical significance of anti-Mullerian hormone (AMH) combined with follicular output rate (FORT) in women of late reproductive age. Methods: A total of 258 women (age range: 35-45 years old) who underwent pre-pregnancy examination in our hospital were collected as the research group (RG), among whom 184 were treated with in vitro fertilization-embryo transfer (IVF-ET). Concurrently, 126 women aged 24-30 years who came to our hospital for pre-pregnancy examination were enrolled as the control group (CG). AMH and FORT were detected and compared between the two groups to analyze the clinical significance of the two in women of late reproductive age. Results: Compared with the CG, AMH was decreased statistically in the RG (P<0.05). AMH was statistically higher in the regular menstrual group than in the menstrual disorder group (P<0.05), and FORT was statistically higher in the pregnancy group in comparison with the non-pregnancy group (P<0.05). AMH decreased with age (P 0.05), while FORT did not correlate with any notable difference among the three subgroups (P 0.05). High, medium and low AMH groups showed no significant difference in the number of retrieved oocytes and transplantable embryos, as well as FORT (P<0.05). A lower AMH level, was correlated with fewer number of retrieved oocytes and transplantable embryos, and higher the FORT level. Significant differences were present among the high, middle and low FORT groups regarding the number of retrieved oocytes and transplantable embryos, the clinical pregnancy rate and AMH level (P<0.05). The lower the level of FORT was, the less the number of retrieved oocytes and transplantable embryos was, the lower clinical pregnancy rate was, and the higher the AMH level was. Conclusions: AMH decreases gradually in women with an increase of age, and FORT can effectively predict pregnancy outcome. AMH detection combined FORT is of great significance in predicting the ovarian reserve function in women of late reproductive age.
引用
收藏
页码:6270 / 6278
页数:9
相关论文
共 50 条
  • [1] Anti-Mullerian Hormone as a Predictor of Time to Menopause in Late Reproductive Age Women
    Freeman, Ellen W.
    Sammel, Mary D.
    Lin, Hui
    Gracia, Clarisa R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05): : 1673 - 1680
  • [2] Association of anti-mullerian hormone levels with obesity in late reproductive-age women
    Freeman, Ellen W.
    Gracia, Clarisa R.
    Sammel, Mary D.
    Lin, Hui
    Lim, Lony Chong-Leong
    Strauss, Jerome F., III
    FERTILITY AND STERILITY, 2007, 87 (01) : 101 - 106
  • [3] Anti-Mullerian hormone levels as a predictor of the pregnancy rate in women of advanced reproductive age
    Sahmay, Sezai
    Oncul, Mahmut
    Tuten, Abdullah
    Tok, Abdullah
    Acikgoz, Abdullah Serdar
    Cepni, Ismail
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2014, 31 (11) : 1469 - 1474
  • [4] Impact of Obesity on Anti-Mullerian Hormone (AMH) Levels in Women of Reproductive Age
    Oldfield, Alexis L.
    Kazemi, Maryam
    Lujan, Marla E.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [5] Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age
    Laven, JSE
    Mulders, AGMGJ
    Visser, JA
    Themmen, AP
    De Jong, FH
    Fauser, BCJM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01): : 318 - 323
  • [6] Fertility in women of late reproductive age: the role of serum anti-Mullerian hormone (AMH) levels in its assessment
    Meczekalski, B.
    Czyzyk, A.
    Kunicki, M.
    Podfigurna-Stopa, A.
    Plociennik, L.
    Jakiel, G.
    Maciejewska-Jeske, M.
    Lukaszuk, K.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (11) : 1259 - 1265
  • [7] Serum anti-Mullerian hormone level and its predictive value for pregnancy outcomes in women of late reproductive age
    He, Y. J.
    Yi, D. N.
    Cai, C. F.
    Zhu, C. Y.
    Zhan, W. T.
    Chen, L.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (06): : 2153 - 2157
  • [8] DECLINE IN ANTI-MULLERIAN HORMONE (AMH) IN A COHORT OF LATE REPRODUCTIVE AGE WOMEN AND ITS ASSOCIATION WITH TIME TO MENOPAUSE
    Sammel, M. D.
    Freeman, E. W.
    Boorman, D.
    FERTILITY AND STERILITY, 2012, 98 (03) : S43 - S43
  • [9] Lower anti-Mullerian hormone levels are associated with HIV in reproductive age women and shorter leukocyte telomere length among late reproductive age women
    Van Ommen, Clara
    Hsieh, Anthony Y. Y.
    Albert, Arianne R.
    Kimmel, Elana
    Cote, Helene C. F.
    Maan, Evelyn C.
    Prior, Jerilynn
    Pick, Neora
    Murray, Melanie C. M.
    AIDS, 2023, 37 (05) : 769 - 778
  • [10] Clinical application of serum anti-Mullerian hormone in women
    Oh, So Ra
    Choe, Sun Yi
    Cho, Yeon Jean
    CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM, 2019, 46 (02): : 50 - 59